MX371011B - Intermediarios y métodos para sintetizar derivados de calicheamicina. - Google Patents

Intermediarios y métodos para sintetizar derivados de calicheamicina.

Info

Publication number
MX371011B
MX371011B MX2016005511A MX2016005511A MX371011B MX 371011 B MX371011 B MX 371011B MX 2016005511 A MX2016005511 A MX 2016005511A MX 2016005511 A MX2016005511 A MX 2016005511A MX 371011 B MX371011 B MX 371011B
Authority
MX
Mexico
Prior art keywords
intermediates
methods
calicheamicin derivatives
synthesizing
synthesizing calicheamicin
Prior art date
Application number
MX2016005511A
Other languages
English (en)
Other versions
MX2016005511A (es
Inventor
Wayne Dugger Robert
Joseph Letendre Leo
Babubhai Patel Vimalkumar
Shastrie Prashad Amarnauth
Zhang Chunchun
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX2016005511A publication Critical patent/MX2016005511A/es
Publication of MX371011B publication Critical patent/MX371011B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/06—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols from sulfides, hydropolysulfides or polysulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26—Separation; Purification; Stabilisation; Use of additives
    • C07C319/28—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/48—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)

Abstract

La presente Invención se relaciona con intermediarios de la Fórmula I (ver fórmula) y a métodos para sintetizar y purificar derivados de calicheamicina.
MX2016005511A 2013-11-04 2014-10-28 Intermediarios y métodos para sintetizar derivados de calicheamicina. MX371011B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361899682P 2013-11-04 2013-11-04
PCT/IB2014/065657 WO2015063680A1 (en) 2013-11-04 2014-10-28 Intermediates and methods for synthesizing calicheamicin derivatives

Publications (2)

Publication Number Publication Date
MX2016005511A MX2016005511A (es) 2016-07-22
MX371011B true MX371011B (es) 2020-01-13

Family

ID=51947406

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016005511A MX371011B (es) 2013-11-04 2014-10-28 Intermediarios y métodos para sintetizar derivados de calicheamicina.

Country Status (18)

Country Link
US (2) US9902691B2 (es)
EP (1) EP3066074B1 (es)
JP (4) JP6494240B2 (es)
KR (1) KR101932824B1 (es)
CN (2) CN105683159B (es)
AU (1) AU2014343268B2 (es)
CA (3) CA3191168A1 (es)
DK (1) DK3066074T3 (es)
ES (1) ES2768611T3 (es)
HK (2) HK1250718A1 (es)
HU (1) HUE047665T2 (es)
IL (1) IL244985B (es)
MX (1) MX371011B (es)
PL (1) PL3066074T3 (es)
PT (1) PT3066074T (es)
RU (1) RU2640197C1 (es)
SI (1) SI3066074T1 (es)
WO (1) WO2015063680A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101630890B1 (ko) 2008-09-10 2016-06-15 콤랩스. 인크. 광역 위치 결정 시스템
HUE047665T2 (hu) * 2013-11-04 2020-05-28 Pfizer Köztitermékek és eljárások kalikeamicin-származékok elõállításához

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US577070A (en) 1897-02-16 Machines
US4970198A (en) 1985-10-17 1990-11-13 American Cyanamid Company Antitumor antibiotics (LL-E33288 complex)
EP0313873B1 (en) * 1987-10-30 1994-09-28 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US5770701A (en) 1987-10-30 1998-06-23 American Cyanamid Company Process for preparing targeted forms of methyltrithio antitumor agents
US5053394A (en) 1988-09-21 1991-10-01 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
IL93733A (en) * 1989-04-14 1996-01-19 American Cyanamid Co History of Dissolved Drug Sulphides Antibacterial and Antibacterial, Prepared from Compounds Containing Methyl-Thriteo Groups and Their Target Form
US5773001A (en) * 1994-06-03 1998-06-30 American Cyanamid Company Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
US8153768B2 (en) * 2002-05-02 2012-04-10 Wyeth Holdings Corporation Calicheamicin derivative-carrier conjugates
WO2007014054A2 (en) * 2005-07-22 2007-02-01 Glaxo Group Limted Benzenesulfonamide inhibitor of ccr2 chemokine receptor
US8142287B2 (en) 2005-10-11 2012-03-27 Zeemote Technology Inc. Universal controller for toys and games
JP2007210974A (ja) * 2006-02-13 2007-08-23 Sankyo Co Ltd 置換されたウレア化合物を含有する医薬
TW200806685A (en) 2006-02-21 2008-02-01 Wyeth Corp Processes for the convergent synthesis of calicheamicin derivatives
CA2663189A1 (en) * 2006-09-12 2008-03-20 Pfizer Products Inc. Benzimidazolone derivatives
DK2155258T3 (en) * 2007-05-22 2017-09-18 Wyeth Llc Improved Methods for Preparing Hydrazides
HUE047665T2 (hu) * 2013-11-04 2020-05-28 Pfizer Köztitermékek és eljárások kalikeamicin-származékok elõállításához
TW201605480A (zh) * 2013-11-04 2016-02-16 輝瑞大藥廠 抗ｅｆｎａ４抗體－藥物結合物

Also Published As

Publication number Publication date
HUE047665T2 (hu) 2020-05-28
US9902691B2 (en) 2018-02-27
RU2640197C1 (ru) 2017-12-27
JP6494240B2 (ja) 2019-04-03
CA2929283A1 (en) 2015-05-07
CN108047287B (zh) 2021-04-27
CN108047287A (zh) 2018-05-18
KR101932824B1 (ko) 2018-12-27
DK3066074T3 (da) 2020-02-10
JP2019089847A (ja) 2019-06-13
HK1250718A1 (zh) 2019-01-11
JP7163439B2 (ja) 2022-10-31
WO2015063680A1 (en) 2015-05-07
US10508081B2 (en) 2019-12-17
EP3066074B1 (en) 2019-12-11
CA2929283C (en) 2022-07-19
SI3066074T1 (sl) 2020-03-31
AU2014343268A1 (en) 2016-05-05
KR20160065944A (ko) 2016-06-09
ES2768611T3 (es) 2020-06-23
AU2014343268B2 (en) 2018-11-15
PL3066074T3 (pl) 2020-05-18
JP2015107963A (ja) 2015-06-11
CN105683159B (zh) 2017-12-19
HK1219721A1 (zh) 2017-04-13
CA3191168A1 (en) 2015-05-07
EP3066074A1 (en) 2016-09-14
MX2016005511A (es) 2016-07-22
CN105683159A (zh) 2016-06-15
JP2021107393A (ja) 2021-07-29
IL244985A0 (en) 2016-05-31
US20180134656A1 (en) 2018-05-17
PT3066074T (pt) 2020-02-03
IL244985B (en) 2019-06-30
JP6854839B2 (ja) 2021-04-07
JP2022183287A (ja) 2022-12-08
US20160251389A1 (en) 2016-09-01
CA3131631A1 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
NZ726859A (en) Synthesis of polycyclic-carbamoylpyridone compounds
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
NZ711192A (en) Process for making benzoxazepin compounds
IN2013MU00848A (es)
PH12016500683A1 (en) Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines
GEP201706626B (en) Synthesis of (s)-nifuratel
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
NZ720106A (en) A process for the preparation of regadenoson
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
PH12016501201A1 (en) Synthesis of ent-progesterone and intermediates thereof
IN2013MU01113A (es)
MX371011B (es) Intermediarios y métodos para sintetizar derivados de calicheamicina.
IN2013MU01290A (es)
IN2013MU04056A (es)
MX2015012523A (es) Metodos para elaborar composiciones antineoplasicas.
MX2015014728A (es) Sintesis de inhibidores de beta secretasa (bace).
MX2014002378A (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
MX2015012902A (es) Sintesis de ent-progesterona e intermediarios de la misma.
IN2015DN01814A (es)
IN2013MU01219A (es)
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MX2015009377A (es) Compuestos radiomarcados.
IN2014MU00069A (es)
IN2013MU01524A (es)
IN2013CH05689A (es)

Legal Events

Date Code Title Description
FG Grant or registration